Search results
Novavax (NASDAQ:NVAX) Trading 3.4% Higher
ETF DAILY NEWS· 6 hours agoHC Wainwright reissued a “buy” rating and issued a $19.00 price objective on shares of Novavax in a research report on Monday, May 13th. TD Cowen raised their price objective ...
Why Novavax (NVAX) Stock Price Appreciated 14% on Monday
Zacks via Yahoo Finance· 3 days agoNovavax (NVAX) surges after one of its top shareholders drops a proxy campaign against the company....
The Next Novavax? 3 Biopharma Stocks to Buy Before They Boom
InvestorPlace· 1 day agoNovavax (NASDAQ:NVAX) stock was among the laggards in the race for the vaccine against COVID-19....
Why Vaccine Stocks Rallied This Week | The Motley Fool
The Motley Fool· 2 hours agoShares of vaccine stocks Moderna (MRNA 0.42%), Novavax (NVAX -3.50%), and BioNTech SE (BNTX -3.23%)...
3 Things You Need to Know If You Buy Novavax Today | The Motley Fool
The Motley Fool· 2 days agoNovavax (NVAX 5.30%) stock has both soared and plummeted at times in recent years. Investors...
Is Novavax Stock a Buy?
The Motley Fool via AOL· 6 days agoBut the underlying business remains risky, and investors are better off staying away despite the hype. Should you invest $1,000 in Novavax right now? Before you buy
This Stock Just More Than Doubled in 1 Day: Is It a Buy?
Motley Fool via Yahoo Finance· 5 days agoNovavax reported positive developments in its latest quarterly update that doubled its share price...
JP Morgan Upgrades Novavax, Inc. (NVAX) to a Neutral from an Underweight – Knox Daily
Knox Daily· 4 days agoPrice Performance Review of NVAX On Friday, Novavax, Inc. [NASDAQ:NVAX] saw its stock fall -9.65% to $13.01. Over the last five days, the stock ...
Novavax Unusual Options Activity For May 23 - Novavax (NASDAQ:NVAX)
Benzinga· 21 hours agoCurrent RSI values indicate that the stock is may be overbought. Next earnings report is scheduled for 75 days from now. Professional Analyst Ratings for Novavax& ...
Novavax, Inc. (NASDAQ:NVAX) Given Average Recommendation of “Hold” by Brokerages
ETF DAILY NEWS· 4 days agoNovavax, Inc. (NASDAQ:NVAX – Get Free Report) has been given an average recommendation of “Hold” by the five analysts that are presently covering the firm, Marketbeat.com ...
